These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 8070754)
1. Transfection of the bcr/abl oncogene into factor-dependent cells by electroporation: acquisition of autonomous proliferation. Takahashi M; Furukawa T; Tanaka I; Ohsawa Y; Nikkuni K; Oaki A; Goto T; Hashimoto T; Kishi K; Koike T Hematol Oncol; 1994; 12(2):53-60. PubMed ID: 8070754 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line. Matulonis U; Salgia R; Okuda K; Druker B; Griffin JD Exp Hematol; 1993 Oct; 21(11):1460-6. PubMed ID: 8405226 [TBL] [Abstract][Full Text] [Related]
3. [Construction of 293pT2-P210 cell line enables expression of bcr/abl to be regulated by Tet-off inducing-expression-system]. Huang WR; Lu ZZ; Wang LS; Wang H; Duan HF; Li QF; Gao CJ; DA WM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):224-8. PubMed ID: 17493320 [TBL] [Abstract][Full Text] [Related]
4. BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line. Ahmed M; Dusanter-Fourt I; Bernard M; Mayeux P; Hawley RG; Bennardo T; Novault S; Bonnet ML; Gisselbrecht S; Varet B; Turhan AG Oncogene; 1998 Jan; 16(4):489-96. PubMed ID: 9484838 [TBL] [Abstract][Full Text] [Related]
6. The BCR-ABL oncogene requires both kinase activity and src-homology 2 domain to induce cytokine secretion. Anderson SM; Mladenovic J Blood; 1996 Jan; 87(1):238-44. PubMed ID: 8547647 [TBL] [Abstract][Full Text] [Related]
7. BCR/ABL confers growth factor independence upon a murine myeloid cell line. Mandanas RA; Boswell HS; Lu L; Leibowitz D Leukemia; 1992 Aug; 6(8):796-800. PubMed ID: 1379313 [TBL] [Abstract][Full Text] [Related]
8. Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells. Stewart MJ; Litz-Jackson S; Burgess GS; Williamson EA; Leibowitz DS; Boswell HS Leukemia; 1995 Sep; 9(9):1499-507. PubMed ID: 7658719 [TBL] [Abstract][Full Text] [Related]
9. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. Wetzler M; Talpaz M; Van Etten RA; Hirsh-Ginsberg C; Beran M; Kurzrock R J Clin Invest; 1993 Oct; 92(4):1925-39. PubMed ID: 8408645 [TBL] [Abstract][Full Text] [Related]
10. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. Li S; Ilaria RL; Million RP; Daley GQ; Van Etten RA J Exp Med; 1999 May; 189(9):1399-412. PubMed ID: 10224280 [TBL] [Abstract][Full Text] [Related]
12. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. Carlesso N; Frank DA; Griffin JD J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285 [TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein. Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K Exp Hematol; 1995 Oct; 23(11):1153-9. PubMed ID: 7556524 [TBL] [Abstract][Full Text] [Related]
14. Pim-1 expression is sufficient to induce cytokine independence in murine hematopoietic cells, but is dispensable for BCR-ABL-mediated transformation. Nosaka T; Kitamura T Exp Hematol; 2002 Jul; 30(7):697-702. PubMed ID: 12135666 [TBL] [Abstract][Full Text] [Related]
15. Acquisition of interleukin-3 independence in FDC-P2 cells after transfection with the activated c-H-ras gene using a bovine papillomavirus-based plasmid vector. Uemura N; Ozawa K; Tojo A; Takahashi K; Okano A; Karasuyama H; Tani K; Asano S Blood; 1992 Dec; 80(12):3198-204. PubMed ID: 1334732 [TBL] [Abstract][Full Text] [Related]
16. IL-2 inhibits proliferation of K562 cells and reduces accumulation of bcr/abl mRNA and oncoprotein. Dilloo D; Hanenberg H; Lion T; Burdach S Leukemia; 1995 Mar; 9(3):419-24. PubMed ID: 7885040 [TBL] [Abstract][Full Text] [Related]